NCT04859374

Brief Summary

Chronic pain is a disabling condition associated with progressive changes and decline in psychological wellbeing. According with a modern conceptualization, pain has to be considered a biopsychosocial disorder where biological, affective, social and psychological aspects are strictly connected. Although this new conceptualization, the implementation of an integral systems approach of psychological tenets into treatments for chronic pain are limited. Concerning treatments of chronic pain condition, the literature of the last years has demonstrated how clinical benefit can be improved when traditional therapies are combined with behavioral approaches in particular mindfulness. Systemic quantitative-somatosensory testing of Conditioned Pain Modulation (CPM) can be considered a measure of endogenous modulation of pain and it has been used in different clinical experiences to evaluate the effectiveness of different pain treatments even if non pharmacological approaches.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 31, 2021

Completed
26 days until next milestone

First Posted

Study publicly available on registry

April 26, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

July 29, 2021

Status Verified

April 1, 2021

Enrollment Period

8 months

First QC Date

March 31, 2021

Last Update Submit

July 28, 2021

Conditions

Keywords

Chronic Pain;Chronic Migraine;Conditioned Pain Modulation;Mindfulness;

Outcome Measures

Primary Outcomes (1)

  • Change of pain intensity

    Mean NRS (Numerical Rating Scale evaluation from the Daily diary card ) difference of at least 2 points on the scale(the scale range is from 0=no pain to 10 =maximum pain perceived) between MIND/TAU and TAU groups assessed by the daily diary card.

    From the first visit to the first follow up at 3 months till the last follow up at 12 months

Secondary Outcomes (7)

  • Change of pain frequency

    6 and 12 months

  • Change of medication intake

    6 and 12 months

  • Neurophysiological indexes

    3, 6 and 12 months

  • Psychological measures - coping strategies

    6 and 12 months

  • Psychological measures - Quality of life

    6 and 12 months

  • +2 more secondary outcomes

Study Arms (2)

Treatment as usual (TAU)

OTHER

Any pharmacological therapy used for managing chronic pain or chronic migraine

Drug: treatment as usual (TAU) (pharmacological)

TAU plus behavioral approach

OTHER

Any pharmacological therapy used for managing chronic pain or chronic migraine added with behavioral approach (mindfulness) delivered on line and smart phone for 6 weekly sessions

Behavioral: MindfullnessDrug: treatment as usual (TAU) (pharmacological)

Interventions

MindfullnessBEHAVIORAL

Behavioral approach (mindfulness) delivered on line and smart phone for 6 weekly sessions

TAU plus behavioral approach

Any pharmacological therapy used for managing chronic pain or chronic migraine

TAU plus behavioral approachTreatment as usual (TAU)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of chronic Migraine and Chronic Neuropathic Pain
  • Written informed consent

You may not qualify if:

  • Co-existent severe medical or psychiatric illnesses
  • Practice of mindfulness in the last 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Migraine DisordersChronic Pain

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Renato Mantegazza, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
None (Open Label)
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 31, 2021

First Posted

April 26, 2021

Study Start

September 1, 2021

Primary Completion

May 1, 2022

Study Completion

May 1, 2022

Last Updated

July 29, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share